Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Aziz Mottiwala

Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $893K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,28670,250 held (−6%) $69.42 $298K -1.9%
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,33065,920 held (−6%) $68.71 $298K -0.9%
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,44061,480 held (−7%) $67.00 $297K +1.6%